GeneDx Holdings Corp.
NMS: WGSLive Quote
About GeneDx Holdings Corp.
Healthcare
Diagnostics & Research
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.
📊 Fundamental Analysis
GeneDx Holdings Corp. demonstrates a profit margin of -4.9%, which is below the sector average, suggesting competitive pressure.
The company recently reported 26.5% revenue growth, which is well above average for the Healthcare sector.
Return on Equity (ROE) is -7.6%, which indicates that capital utilization is currently under pressure.
At a current price of $59.62, WGS currently trades near the bottom of its 52-week range (4%), indicating potential value or weakness (Range: $55.17 - $170.87).
🏥 Financial Health
🔴
Profit Margin
Weak
✅
Debt/Equity
Excellent
✅
Revenue Growth
Excellent
🔴
Return on Equity
Weak
🔴
Beta (Risk)
High Volatility
Key Financials
Market Cap
$1.54B
Trailing P/E
--
Forward P/E
28.98
Beta (5Y)
2.19
52W High
$170.87
52W Low
$55.17
Avg Volume
779K
Day High
Day Low
📡 Subscribe to ZcoreAI updates
Join the list to get access to:
- Z-Score signals at market open
- New app features and updates
- Exclusive promo for ZcoreAI App